Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-818-0 | CAS number: 126-99-8
Endpoint summary
Administrative data
Description of key information
In vivo data for skin irritancy indicate moderate irritation potential (Anon 1970, OECD SIDS 1998). No in vitro assessment of skin irritancy is considered necessary.
An in vivo assessment of conjunctival reactions in rabbits indicated that chloroprene elicited conjunctivitis with recovery within ten days after instillation (OECD SIDS 1998). Evdience in humans and animal studies indicates that chloroprene may cause respiratory irritation.
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Additional information
There is limited information on the skin and eye irritation potential of chloroprene (Anon 1970, OECD SIDS 1998). Studies in rabbits indicate that both dermal and ocular responses are likely following exposure to chloroprene. Studies have not shown chloroprene to be corrosive to the skin. An in vivo assessment of conjuctival reactions in rabbits indicated that chloroprene elicited conjunctivitis which lasted for 10 days.
The OECD SIDS (1998) for chloroprene reports that the primary effects of acute exposure to high concentrations in air in humans are irritation of the skin and mucous memrbranes, CNS depression and respiratory difficulties - no further details are provided.
In repeated dose inhalation studies conducted by NTP (NTP, 1998), hypoactivity, unsteady posture and rapid, shallow breathing occurred after a single exposure and bloody noses were observed after the second day of exposure. Bronchial and bronchiolar degeneration have been seen in rodents 2 days following exposures at 19.58 mg/l.
Effects on skin irritation/corrosion: moderately irritating
Effects on eye irritation: irritating
Effects on respiratory irritation: irritating
Justification for classification or non-classification
According to Annex VI to Regulation (EC) No 1272/2008, chloroprene is classified for irritancy hazard as: Eye Irrit. (H319) – Causes serious eye irritation, STOT SE 3 (H335) – May cause respiratory irritation and Skin Irrit (H315) – Causes skin irritation.
Based on the evaluation of available data, the classification of chloroprene for skin, eye and respiratory irrtiation is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
